16S rRNA Sequencing Lab Queue Active — Next Batch Shipping Within 24h
Metagenomic Science & ISO 22716

16S rRNA Genomic Sequencing & Micro-pH Calibration

Our research team maps skin microbiome taxonomy at hypervariable V3-V4 region resolution to compound bio-active serums that target true underlying dysbiosis.

THE 3-ACT CLINICAL ARCHITECTURE

How Biometric Skincare Outperforms Generic Products

Moving beyond static off-the-shelf creams to genomic precision compounding.

ACT IMapping your dermal microbial DNA

16S Genomic Sequencing

Your bilateral cheek swab undergoes 16S rRNA gene amplicon sequencing. We analyze over 100,000 bacterial reads to quantify commensal species (Staphylococcus epidermidis) versus pathogenic strains (Cutibacterium acnes IA1).

  • High-Throughput NextSeq DNA Assay
  • Trans-Epidermal Water Loss (TEWL) indexing
  • Micro-pH acid mantle calibration
  • Bacterial dysbiosis scoring (0 - 100 baseline)
Lab Protocol ACT I
"Skin health is governed by bacterial equilibrium, not cosmetic superficial fragrances."
100% Biocompatible Formula
SCIENTIFIC GOVERNANCE

Scientific Advisory Board & Clinical DOIs

DM

Dr. Marcus Sterling, PhD

Director of Cutaneous Genomics

Zurich Institute of Molecular Dermatology

Pioneered 16S rRNA high-throughput sequencing protocols for human dermal biomes. Author of 42 peer-reviewed papers on micro-organism cross-talk.

DH

Dr. Hadiya Al-Mansoor, MD, PhD

Professor of Dermatological Biochemistry

Cambridge Bioscience Research Centre

Leading authority on extremity extremophiles and cellular osmolytes. Recipient of the International Society for Investigative Dermatology Gold Medal.

PJ

Prof. Jean-Luc Moreau

Head of Peptide Synthesis Laboratory

École Polytechnique Fédérale de Lausanne

Over 25 years of research into synthetic biomimetic peptides and liposomal trans-dermal delivery systems.